Afghanistan vs Kenya: The number of people with susceptibility test result for rifampicin
Afghanistan
17,443
in 2021
Kenya
24,832
in 2021
Afghanistan rank
16th
Kenya rank
13th
The number of people with susceptibility test result for rifampicin over time
- Afghanistan
- Kenya
How they compare
Kenya currently reports 24,832 against 17,443 in Afghanistan, a difference of 7,389.
That makes Kenya's figure about 1.4 times Afghanistan's.
Across all 5 years both countries report, Kenya has been ahead every year.
Afghanistan ranks 16th and Kenya ranks 13th of 155 countries.
Kenya has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Afghanistan | Kenya | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 6,121 | 29,916 | 23,795 | Kenya |
| 2020s | 13,849 | 28,802 | 14,952 | Kenya |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Afghanistan or Kenya?
- Kenya, at 24,832 against 17,443 in Afghanistan as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Afghanistan and Kenya?
- 7,389, with Kenya ahead.
- How many years of comparable data are there for Afghanistan and Kenya?
- 5 years are reported by both, from 2017 to 2021.
- How do Afghanistan and Kenya rank globally for the number of people with susceptibility test result for rifampicin?
- Afghanistan ranks 16th and Kenya ranks 13th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.